OrbiMed Sets $300M Goal For Asia Fund

New York-based healthcare focused private equity firm OrbiMed has initiated the process to raise $300 million for its second pan-Asia healthcare fund, the investment firm disclosed in a filing with SEC. The firm is looking to complete fundraising for OrbiMed Asia Partners II within a year, according to the filing.